Adagio Medical Holdings, Inc. (ADGM): Long-Term Debt

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2024-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$21.04M

As of 2025-12-31

$24.84M

As of 2026-06-30

2023-12-31 Long-Term Debt (USD) 2025-12-31

Period ended	Long-Term Debt	Change YoY	Source filing
2025-12-31	$21.04M	+22.5%	2026-03-27, Balance as of period end
2024-12-31	$17.18M	n/c	2026-03-27, Balance as of period end
2023-12-31	$38.27M	n/a	2025-03-27, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Long-Term Debt	Change YoY
Adagio Medical Holdings, Inc. (ADGM)	2025-12-31	$21.04M	+22.5%
Baxter International Inc (BAX)	2025-12-31	$9.44B	-28.4%
3M Co (MMM)	2025-12-31	$12.60B	-3.4%
Teleflex Inc (TFX)	2025-12-31	$2.64B	+59.5%
West Pharmaceutical Services Inc (WST)	2025-12-31	$202.80M	+0.1%
Haemonetics Corp (HAE)	2026-03-28	$1.24B	-0.5%
Utah Medical Products Inc (UTMD)	2025-12-31	$0	n/a
Apyx Medical Corp (APYX)	2025-12-31	$37.50M	0.0%
Artivion, Inc. (AORT)	2025-12-31	$215.11M	-31.6%

Compare ADGM, BAX, MMM, TFX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗